山东新华医疗器械股份有限公司关于终止收购武汉中帜生物科技股份有限公司36.1913%股权的公告

Group 1 - The company, Shandong Xinhua Medical Instrument Co., Ltd., has decided to terminate the acquisition of a 36.1913% stake in Wuhan Zhongzhi Biotechnology Co., Ltd. due to the expiration of the delivery deadline as stipulated in the share transfer agreement [2][3]. - The termination was agreed upon after friendly negotiations with all parties involved, including Shenzhen Meijian Electronic Technology Development Co., Ltd. and others, leading to the signing of a supplementary agreement [3]. - The company has not made any payments related to the acquisition, and the termination will not adversely affect its current operating performance or financial status [4]. Group 2 - The company expressed its commitment to continue seeking development opportunities and enhancing its core competitiveness despite the termination of the acquisition [4]. - The company apologized for any inconvenience caused to investors and expressed gratitude for their ongoing support [4].